PAR paradigm biopharmaceuticals limited..

Morning all-adding to observations the line in the report that...

  1. 274 Posts.
    lightbulb Created with Sketch. 27
    Morning all-adding to observations the line in the report that tickled my fancy was
    "Paradigm’s focus will now shift to the initiation and recruitment of Australian patients with Knee OA for,PARA-008 which will evaluate biomarkers in PPS treated subjects, and the Pivotal Phase 3 clinical trials for drug registration."

    Almost ironic that the phase 3 trial results is an afterthought.wink.png
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
43.0¢
Change
-0.035(7.53%)
Mkt cap ! $170.8M
Open High Low Value Volume
47.0¢ 47.5¢ 42.0¢ $676.1K 1.519M

Buyers (Bids)

No. Vol. Price($)
2 16161 43.0¢
 

Sellers (Offers)

Price($) Vol. No.
44.5¢ 19584 1
View Market Depth
Last trade - 16.10pm 07/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.